Announcements Trials
Browse Landscape

Phase

Phase 2 3

Status

Completed 2Recruiting 1

Sponsor Class

INDUSTRY 3

Study Type

Interventional 3

Sponsor

Cancer Type

Other 3Head & Neck 3

Conditions

Mucositis 4Stomatitis 3Head and Neck Neoplasms 3Mouth Neoplasms 2Polycystic Ovary Syndrome 1Pain 1Obesity 1Neoplasms 1Infertility, Female 1Infertility 1Carcinoma, Squamous Cell 1

Interventions

Injections 3aluminum hydroxide, magnesium hydroxide, drug combination 2Xylitol 2Water 2Radiotherapy 2RRx-001 2Propolis 2Low-Level Light Therapy 2Lidocaine 2Honey 2Diphenhydramine 2Cisplatin 2peppermint oil 1hydrated silica gel-based toothpaste 1golotimod 1calcium phosphate 1brilacidin 1anise oil 1amlexanox 1Traumeel S 1Sorbic Acid 1Sodium Chloride 1Sodium Bicarbonate 1Radiotherapy, Intensity-Modulated 1Poloxamer 1Phosphatidylinositol 3-Kinases 1Glycerol 1Glutamine 1Folic Acid 1Fibroblast Growth Factor 7 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Stomatitis × Injections × Other × Clear all
NCT05966194 2024-11-15

KEVLARx

EpicentRx, Inc.

Phase 2 Recruiting
216 enrolled
Head & NeckOther

Carcinoma, Squamous Cell, Head and Neck Neoplasms, Mouth Neoplasms, Stomatitis, Mucositis

NCT03515538 2024-11-04

PREVLAR

EpicentRx, Inc.

Phase 2 Completed
53 enrolled 15 charts
Head & NeckOther

Head and Neck Neoplasms, Mouth Neoplasms, Stomatitis, Mucositis

NCT02324335 2019-01-16

Brilacidin

Innovation Pharmaceuticals, Inc.

Phase 2 Completed
61 enrolled 12 charts
Head & NeckOther

Head and Neck Neoplasms, Stomatitis, Mucositis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡